In an Australian-first and huge step in STI prevention for Australian women, the Therapeutic Goods Administration has approved Touch Biotechnology’s new sexually transmitted infection (STI) self-test kit for Chlamydia and Gonorrhoea, providing greater privacy and fast results.
The first of its kind in Australia, the highly accurate self-test kit detects Chlamydia and Gonorrhoea with one swab sample, producing a positive or negative result for both infections in 15 minutes.
Chlamydia is the most reported communicable disease in Australia, with over 110,000 reported cases in 2023, but often appears asymptomatic and as a result, some cases are undiagnosed, with people reluctant to test for the infection due to perceived stigma or lack of awareness, while Gonorrhoea presents itself with pain or discomfort in the throat, eyes, cervix and other areas but similarly, it is often mistaken for other infections and remains undiagnosed.
